Collegium Pharmaceutical, Inc (COLL) stock
COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/3045% below fair value
$24.81+0.34 (+1.39%)
Close on Nov 11, 2026Market cap $807.71MP/E 24.8Yield –
Collegium Pharmaceutical enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Collegium Pharmaceutical's enterprise value was $676.82M on Nov 11, 2026, against $1.19B a year earlier. Over the last 5 years it ranged from $352.88M to $1.19B, with a median of $713.08M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $676.82M | -42.5% |
| 2025 | Dec 31, 2025 | $1.18B | +46.5% |
| 2024 | Dec 31, 2024 | $803.43M | +12.7% |
| 2023 | Dec 29, 2023 | $713.08M | +9.8% |
| 2022 | Dec 30, 2022 | $649.46M | +42.2% |
| 2021 | Dec 31, 2021 | $456.77M | -13.4% |
| 2020 | Dec 31, 2020 | $527.16M | -1.7% |
| 2019 | Dec 31, 2019 | $536.08M | +24.4% |
| 2018 | Dec 31, 2018 | $431.03M | -6.3% |
| 2017 | Dec 29, 2017 | $460.22M | +66.6% |
| 2016 | Dec 30, 2016 | $276.25M | -40.4% |
| 2015 | Dec 31, 2015 | $463.46M | – |
See a number that looks wrong?